About Alpelisib
Class: | PI3K inhibitor
Use: | Treatment of HR-positive, HER2-negative breast cancer in combination with endocrine therapy in postmenopausal women and men with PIK3CA mutations
Adult dose: | 300 mg orally once daily, taken with food
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Hyperglycemia, rash, diarrhea, nausea, fatigue, decreased appetite, and stomatitis
Contraindications: | Hypersensitivity to alpelisib or any component of the formula
Drug Class
PI3K inhibitor
Uses & Indications
Treatment of HR-positive, HER2-negative breast cancer in combination with endocrine therapy in postmenopausal women and men with PIK3CA mutations
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F)
Manufacturer & Packaging
Manufacturer: Novartis Pharmaceuticals Corporation, U.S.A
Package Size
28s
Price & Supplier
Price in UAE: AED 28240.50
Dosage Information
Adult Dose
300 mg orally once daily, taken with food
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Hyperglycemia, rash, diarrhea, nausea, fatigue, decreased appetite, and stomatitis
Contraindications & Precautions
Hypersensitivity to alpelisib or any component of the formulation; severe hepatic impairment
Important Warnings
Risk of severe hyperglycemia; monitor blood glucose levels; may cause severe skin reactions; potential for pneumonitis; monitor for signs of infection
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.